Natco Pharma raises its ownership stake in South Africa’s Adcock Ingram to 49% through a transaction valued at about ZAR 1.81 billion (roughly ₹1,060 crore at the prevailing exchange rate). The deal involves Natco Pharma increasing its shareholding, taking its stake to the 49% level in Adcock Ingram. The reported valuation reflects the consideration paid for the additional stake, with both sources citing the same target ownership percentage and the same deal value in South African rand and Indian rupees. The information indicates that the transaction is part of Natco Pharma’s strategy to expand its investment and influence in the South African company. No further details about the timing of completion, funding sources, or any changes in governance or management are included in the provided excerpts.